Red blood cells retain a memory of high-altitude exposure, allowing for faster acclimation next time. But that memory fades within four months. Christopher Intagliata reports.
No one wants active viral outbreaks—but researchers need them to make sure vaccinations work
Some advanced cancers can now be successfully treated by synthetic immune cells that are more powerful and longer-lasting than any found in the body
Functional intestine becomes the latest lab-grown organ
10 years of FDA data paint a grim picture of teething product complaints
Merck halts a late-stage trial of verubecestat, which targeted an enzyme involved in brain plaque formation
Recently we talked about the two-way connection between the brain and the small and large intestines (aka the gut). This week, Savvy Psychologist Dr. Ellen Hendriksen continues our journey through the gut by investigating the link between heartburn drugs and dementia
Doctors and patients are grappling with the unsettling finding that chronic use of popular heartburn medicines may be riskier than was thought
Suddenly in demand, naloxone injector goes from $690 to $4,500
Trevor Mundel, president of global health at the Gates Foundation, talks to Scientific American editor-in-chief Mariette DiChristina about the Coalition for Epidemic Preparedness Innovations (CEPI) and the efforts to create vaccine platforms for rapid responses to epidemics.
Researchers see some promise in ibogaine, a well-known hallucinogen, and related compounds
China has been using colistin to speed growth of farm animals
Millions of patients depend on a rare radioactive form of one element to scan them for disease. But the old nuclear reactors that make it are shutting down
The small molecules cleared and prevented tau buildup in mice and monkeys
When LSD binds to serotonin receptors, it pulls a "lid" closed behind it, locking it in place for hours, and explaining its long-lasting effects. Christopher Intagliata reports.
Blood tests can be highly unreliable
Funnel web venom needed after a dry spell triggers more bites
A few early-stage clinical trials are underway
Scientific American executive editor Fred Guterl talks with Pres. Obama’s science advisor, John Holdren, about climate science, space travel, the issue of reproducibility in science, the brain initiative and more.
A virus that infects bacteria listens to messages from its relatives when deciding how to attack its hosts